Filing summary
Company: Microbot Medical Inc. (NASDAQ: MBOT). Filing: Form 8-K, dated September 25, 2026.
Business context and reporting period
The filing reports a Regulation FD disclosure announcing that the company disseminated a press release updating certain growth strategies. This is a current-event filing, not a periodic financial report.
Financial and operating metrics
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Changes, outlook, and risks
The filing does not describe the growth-strategy changes, provide guidance or forecasts, or discuss related risks, contingencies, or unusual items. The referenced press release is not included in the supplied text.
Investor verification
- Obtain and review the referenced press release for the substance of the growth-strategy update.
- Confirm the exhibit reference: Item 7.01 identifies Exhibit 99.1, while the exhibit list labels the press release as Exhibit 10.1.
- Check subsequent company disclosures for implementation details, financial implications, and any updated guidance.